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ABSTRACT    
 
BACKGROUND: An estimated 68% of the Ethiopian population, 
living in 75% of the landmass, is at risk of contracting malaria at 
any time making it the leading public health problem. The 
temporal analysis of malaria data could be important to evaluate 
the performance of malaria prevention programmes. Thus, the aim 
of this study was to determine the trend of malaria at Woreta 
Health Center (WHC) over a period of five years. 
METHODS: We analyzed the records of 8,057 presumptive 
malaria patients registered in 2012 to 2016. The following patient 
data were retrieved from laboratory registration logbook for 
analysis: sex, age, residence, blood film (BF) microscopy result, 
type of malaria parasite identified, year and month when the 
patients visited WHC. Logistic regression was employed to assess 
the association between potential associated factors and positive 
BF result; p < 0.05 was considered significant. 
RESULTS:  Among the total presumptive individuals, 4447(55.2%) 
were females. The prevalence of malaria in each year ranged from 
4.1% to 6.7%. The overall prevalence of malaria was 5.4% (95%CI: 
4.9%-5.9%). The two most important species of malaria parasite 
identified were P. falciparum at 233(53.7%) and P. vivax at 
184(42.4%). Relatively higher proportions of cases were 
documented in the months of November, December and June 
(11.1%, 8.1% and 7.2%, respectively). Patients who visited the 
health center in the month of December were >4 times more likely 
to be infected as compared with those who came to the health 
center in September [AOR: 4.2, 95%CI (2.374-7.560)]. Females 
were 1.3 times more likely to be infected than males, [AOR: 1.3, 
95%CI (1.101-1.638)]. Similarly, patients in the age group above 
15 were 1.9 times more likely to be infected than individuals < 5, 
[AOR: 1.9 95%CI (1.498-2.455), p value 0.000].  
CONCLUSION: In the studied area, malaria remains a major 
public health challenge. Hence, interventions to decrease the 
impact of the disease have to be evaluated and strengthened.  
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Malaria is one of the major public health problems 
around the world. Despite being preventable and 
treatable, malaria continues to have a devastating 
impact on people’s health and livelihoods around 
the world (1-5).  According to the latest available 
data, about 3.2 billion people, nearly half the 
world’s population, remained at risk of malaria in 
97 countries, territories and areas in 2013, and an 
estimated 198 million cases occurred.  In the same 
year, the disease killed about 584,000 people, 
mostly children aged under 5 years, in sub-
Saharan Africa (6). In 2015 alone, there were 214 
million new cases of the disease and more than 
400,000 malaria-related deaths around the globe 
(5).  More than 90% of clinical cases and death 
due to malaria occur in Africa (7). Of those 
Africans who die from malaria each year, most are 
children under 5 years of age (8) and pregnant 
women due to low level of immunity (4). In 2015, 
the African region accounted for approximately 9 
in 10 malaria cases and deaths globally (5). 
About 75% of the landmass of Ethiopia is 
malarious, an estimated 68% (~52million) of the 
population are at risk of contracting malaria 
(9,10). According to the world malaria report of 
the year 2016, the number of people living in high 
transmission (>1 case per 1000 population) and 
low transmission (0-1 cases per 1000 population) 
areas in Ethiopia was estimated to be 27,000,000 
(27%) and 40,600,000 (41%), respectively. 
According to this report, there were 662 reported 
deaths due to malaria in the country (11). The 
exact number of people getting sick with and 
dying of malaria every year in Ethiopia is not well 
known due to poor documentation. However, it is 
known that millions of people get sick and tens of 
thousands die due to malaria every year, and that 
rates of mortality and morbidity dramatically 
increase during epidemics (9,10). Plasmodium 
falciparum and P. vivax are the two most 
dominant malaria parasites in Ethiopia (12,13). 
They are prevalent in all malaria endemic areas in 
the country with P. falciparum representing about 
65-75% of the total reported malaria cases, 
relative frequency varying in time and space 
within given geographical ranges. P. malariae and 
P.ovale are rare and account for <1% of all 
confirmed malaria cases. According to the world 
malaria report of the year 2016, the predominant 
Plasmodium species identified in Ethiopia were: 
P. falciparum (64%) and P.vivax (36%) (11). The 
major malaria vector incriminated in Ethiopia is 
Anopheles arabiensis (12) with A. funestus, A. 
pharoensis and A. nili being secondary vectors 
(13).  
The distribution of malaria in Ethiopia is not 
uniform (9) and is seasonal in most parts of the 
country with variable transmission and prevalence 
patterns affected by the large diversity in altitude, 
rainfall and population movement. In most parts of 
Ethiopia, the major transmission periods of 
malaria occurs from September to December, 
following the main rainy seasons (June-
September). The minor one is from March to May, 
following small showers of rain in autumn (12, 
14). Since peak malaria transmission often 
coincides with the planting and harvesting season, 
and the majority of malaria burden is among older 
children and working adults in rural agricultural 
areas, there is a heavy economic burden in 
Ethiopia (13).  
Ethiopia has achieved a remarkable progress 
in the fight against malaria during the most recent 
decade through strong preventive and case 
management interventions with large engagement 
of the health extension workers (HEWs) and the 
health development army (HAD) volunteers 
providing community based care at the household 
level. The country is also one of the few sub-
Saharan African countries that have shown 
progress in the fight against malaria (15). Because 
of the inadequacy of malaria case data from many 
sub-Saharan African countries including Ethiopia 
(16), health facility based prevalence studies, like 
this study, can be used to enhance understanding 
of the level of malaria and how it is changed over 
time. The findings would also help policy makers 
to assess their malaria prevention strategies and 
their degree of interventions. Moreover, the 
epidemiological picture of malaria is not yet 
determined in the study area. Hence, the aim of 
this study was to determine the trend of malaria at 
Woreta Health Center (WHC), Northwest 
Ethiopia, over a period of five years.  
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MATERIALS AND METHODS 
 
Study design, setting and data collection: In this 
study, the authors analyzed the records of 8,057 
clinically suspected malaria patients who had 
blood film (BF) examinations for malaria 
parasites. The study was conducted at WHC. 
Woreta is a town in Northwestern Ethiopia. 
According to figures from the Central Statistical 
Agency of Ethiopia in 2005, the twon had an 
estimated total population of 26,317. The town is 
located approximately 610 km Northwest of Addis 
Ababa, the Capital of Ethiopia, having an 
elevation of about 1828 meters above sea level. 




All patients who visited the health center 
from 1 September 2011 to 30 August 2016 and 
had the following registered data were included 
for analysis: sex, age, residence, BF microscopy 
result (+, -), type of malaria parasite identified (P. 
falciparum, P. vivax or mixed), year and month 
when the patients visited the health center. 
Patients were suspected for malaria when they 
presented with fever and related clinical 
symptoms. Data were retrieved directly from 
laboratory registration logbook using prepared 
data extraction sheet. 
 
Blood film microscopy procedure: Microscopic 
examination remains the "gold standard" method 
for laboratory confirmation of malaria in 
developing nations, like Ethiopia. The Woreta 
Health Center is using BF as a standard procedure 
to diagnose malaria among suspected patients. 
Capillary blood samples were collected from each 
presumptive patient for microscopic examination. 
The finger tip or heal of the child patient was 
cleaned with swab moistened with 70% v/v 
alcohol. After air-drying, a sterile lancet was used 
to prick the finger or heel, and then squeezed 
gently to obtain the blood (17). Two blood 
samples for thick and thin films were prepared on 
clean slides from each participant according to the 
standard WHO approved protocol. Slides were 
labeled properly and air-dried horizontally on a 
slide tray. Thin films were fixed with absolute 
methanol immediately after drying, and both thin 
and thick blood films were stained with 3% 
Giemsa solution for 30 minutes. During 
examination, blood slides were read as either 
negative, P. falciparum positive, P.vivax positive, 
or mixed infection. Two hundred fields (the 
equivalent of 0.5μl of thick blood film) were 
examined at a magnification of 1000x before 
identifying a slide as negative. If positive, the thin 
film was read to determine the species (17,18). 
Data analysis: All data were entered, cleaned and 
analyzed using Statistical Package for Social 
Science (SPSS) software (IBM Corp. Released 
2011. IBM SPSS Statistics for Windows, Version 
23.0. Armonk, NY: IBM Corp.). Descriptive 
statistics, like proportion and mean, was used to 
present data. Logistic regression was employed to 
assess the association between potential predictors 
and malaria infection.  P value less than 0.05 was 
considered to indicate statistically significant 
difference. 
Ethical approval and consent: Permission and 
consent from WHC administrators was obtained to 
use the data for the research purpose. No patient 
details that may link to the patient identity, like 





Demographic characteristics of study 
participants: The authors assessed BF 
microscopic results of 8,057 malaria suspected 
patients from laboratory reporting logbook 
processed over a 5 years’ period in WHC. Of the 
total patients registered, 4447(55.2%) were 
females. The median age of the patients was 25 
years, ranging from 1 month to 85 years. Among 
the participants, 5062 (62.8%) and 6176 (76.7%) 
were from rural settings and in the age group of 
above 15 years, respectively (Table 1). 
Prevalence of malaria and its trend: The 
number of clinically suspected malaria patients 
who visited the WHC over the five years’ period 
was comparable, ranging from 1473(17.5%) in 
2012 to 1766(21.9%) in 2015 (Figure 1).  
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Number of presumptive malaria cases
Number of confirmed malaria cases
Figure 1: Number of BF confirmed and 
presumptive malaria cases over the five years 
period at WHC, 2012-2016 
Similarly, the prevalence of BF confirmed malaria 
cases in each year ranged from 4.1% in 2016 to 
6.3% in 2014 (Figure 2). The overall prevalence of 
malaria among suspected cases was 5.4% 
(434/8057, 95%CI: 4.9%-5.9%) over the five 
years’ period. When we look at the annual 
distribution of malaria in the five years’ period, 
relatively higher proportions of confirmed cases 
were documented in the months of November, 
December and June at 11.1%, 8.1% and 7.2%, 
respectively (Figure 3). The two most important 
species of malaria identified were P. falciparum, 
233(53.7%, 95%CI: 49%-58.3%), and P. vivax, 
184(42.4%, 95%CI: 37.8%-47.1%). There were 
17(3.9%, 95%CI: 2.5%-6.6%) reports of mixed 
infection with both species (Table 1).  
 
 
Table 1: Socio-demographic characteristics of the 
study participants and distribution of malaria at 
WHC, 2012-2016. 
 

















Mean age 26.1 years 
SD 15.4 years 
Median age 25.0 years 












434 (5. 4) 
7623(94.6) 
Identified malaria parasites 





















605 (7.5)  
585 (7.3)  
467 (5.8)  
552 (6.9)  
668 (8.3)  
846 (10.5)  
504 (6.3)  
492 (6.1)  
885 (11.0)  
995 (12.3)  
















              
                  Five Years Malaria Trend Analysis…                                                      Awoke D. et al.                                       
 
 




2012 2013 2014 2015 2016
Prevalence of malaria in each 
year (row %)
5.1 4.4 6.3 6.7 4.1
Didtribution of all confirmed 
malaria cases across the five 
years period( column %)










Figure 2: Prevalence of malaria over the five years period at WHC, 2012-2016. 
 
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Prevalence of malaria in each
month (row %)
3.6 4.6 6.9 2.4 3.3 7.2 6.3 1.6 3.7 4.6 11.1 8.1
Distribution of all confirmed
malaria cases across the five
years period(column %)









Figure 3: Annual distribution of malaria over the five years period at WHC, 2012-2016. 
 
 
Factors associated with BF confirmed malaria: 
In the logistic regression model, it was found that 
females were 1.3 times more likely to be infected 
with malaria than males, [AOR: 1.3, 95%CI 
(1.101-1.638), p value 0.004]. Similarly, patients 
in the age group above of 15 were 1.9 times more 
likely to be positive for malaria than individuals 
under the age of 5, [AOR: 1.9 95%CI (1.498-
2.455), p value 0.000]. Moreover, patients who 
visited the health center in 2016 were 1.6 times 
more likely to be infected than those who came in 
2012 to the center, [AOR: 1.6, 95%CI (1.133-
2.214), p value 0.007]. On top of this, patients 
who visited the WHC in the month of December 
were more than 4 times more likely to be infected 
as compared with those who came in September 
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[AOR: 4.2, 95%CI  (2.374-7.560),  p value 0.000]. 
The distribution of malaria also showed a 
significant difference in the months of November, 
January, April, July and August (p value <0.05) 
(Table 2). 
 
Table 2: Logistic regression analysis of factors associated with BF confirmed malaria cases among   
suspected cases in WHC, 2012-2016. 
 
 
Variables   n  (%) of Bf positives    n  (%) of  BF negatives   
COR (95%CI) 
 
AOR (95%CI), p value 
Sex      
Male  232 (6.4) 3378 (93.6) 1.0 1.0 
Female  202 (4.5) 4245 (95.5) 1.4 (1.189-1.752) 1.3 (1.101-1.638), 0.004 
Age group in years     
<5 47 (5.7) 775 (94.3) 1.0 1.0 
5-15 96 (6.3) 963 (93.7) 0.6 (0.424-0.873) 1.2 (0.845-1.606), 0.352 
>15 291 (4.7) 5885 (95.3) 1.2 (0.893-1.684) 1.9 (1.498-2.455), 0.000 
Residence       
Urban  141 (4.7) 2854 (95.3) 1.0 1.0 
Rural  293 (5.8) 4769 (94.2) 0.8 (0.653-0.987) 0.8 (0.660-1.003), 0.053 
Month      
Sep 33 (3.7) 852 (96.3) 1.0 1.0 
Oct 46 (4.6) 949 (95.4) 0.8 (0.506-1.261) 0.5 (0.224-1.288), 0.164 
Nov 73 (11.1) 587 (88.9) 0.3 (0.204-0.476) 1.9 (1.027-3.535), 0.041 
Dec 65 (8.1) 733 (91.9) 0.4 (0.284-0.671) 4.2 (2.374-7.560), 0.000 
Jan 22 (3.6) 583 (96.4) 1.0 (0.592-1.778) 3.3 (1.871-5.717), 0.000 
Feb 27 (4.6) 558 (95.4) 0.8 (0.476-1.346) 1.4 (0.705-2.816), 0.332 
Mar 32 (6.9) 435 (93.1) 0.5 (0.319-0.868) 1.6 (0.840-3.206), 0.174 
Apr 13 (2.4) 539 (97.6) 0.3 (0.134-0.494) 2.0 (1.122-3.543), 0.019 
May 22 (3.3) 646 (96.7) 0.5 (0.224-0.896) 0.8 (0.385-1.559), 0.474 
Jun 61 (7.2) 785 (92.8) 0.2 (0.107-0.360) 1.5 (0.782-2.822), 0.226 
Jul 32 (6.3) 472 (93.7) 0.2 (0.117-0.433) 2.6 (1.448-4.508), 0.001 
Aug 8 (1.6) 484 (98.4) 0.9 (0.380-2.243) 2.2 (1.148-4.275), 0.018 
Year     
2012 75 (5.1) 1338 (94.9) 1.0 1.0 
2013 73 (4.4) 1598 (95.6) 1.2 (0.882-1.707) 1.6 (0.980-2.722), 0.059 
2014 101 (6.3) 1503 (93.7) 0.8 (0.613-1.135) 1.0 (0.965-1.459), 0.971 
2015 119 (6.7) 1647 (93.3) 0.8 (0.576-1.045) 1.2 (0.817-1.811), 0.335 




Malaria is the world’s deadliest mosquito-borne 
disease. The African continent continues to bear 
the greatest burden of malaria and the greatest 
diversity of parasites, mosquito vectors and human 
victims (19). Ethiopia's complex topography and 
seasonal rainfall largely support its transmission, 
and it makes one of the public health challenges in 
the country. 
This study area is one of the potentially malarious 
localities in Ethiopia. The number of malaria 
suspected individuals and tested in WHC over the 
five years’ period ranged from 1473 (17.5%) in 
2012 to 1766 (21.9%) in 2015. Moreover, the 
prevalence of confirmed malaria cases in each 
year ranged from 4.1% in 2016 to 6.7% in 2015, 
making the overall prevalence of malaria 5.4%, 
(95%CI: 4.9% - 5.9%). According to the world 
malaria report of 2016, the number of malaria 
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471
suspected and tested individuals in public health 
facilities of Ethiopia showed increment from about 
9% in 2005 to 38% in 2015. However, the 
prevalence of BF confirmed malaria among these 
suspected cases over these periods ranged from 
1% to 4%; the highest, (4%), was recorded in the 
year 2013 (11). The finding of this study is in 
agreement with the nationwide estimate although a 
minor difference was observed which might be 
related to the difference in sample size. Similarly, 
according to the Ethiopian 2011 malaria indicator 
survey, malaria prevalence was reported to be 
1.3% (13,15) which makes our finding a bit higher 
than  this report. However, other similar studies in 
Ethiopia demonstrated 14.8-25.6% (20,21) 
prevalence which is quite higher than our finding 
and the national estimate. The disparity might be 
related to the difference in geographical location, 
season and the employed sample size.  
The two most important species of malaria 
identified in this study were P. falciparum at 233 
(53.7%) and P. vivax at 184 (42.4%). There were 
17(3.9%) reports of mixed infections. This result 
was comparable with the national prevalence 
study where about 57% and 43% of malaria cases 
in Ethiopia are accounted to P. falciparum and P. 
vivax, respectively (1). Similar findings were also 
reported in other studies in Ethiopia (20,22). 
Furthermore, different literatures indicated that P.  
falciparum is responsible for the most common 
form of malaria in Ethiopia (15). According to the 
WHO malaria report (7), P. falciparum is most 
prevalent in the African continent, and is 
responsible for most deaths. The report also 
indicated that P. vivax accounts for about 38% of 
the reported cases in Ethiopia which is concurring 
with the finding of this study.  
  In this study, the annual distribution of 
malaria in the five years’ period showed that 
higher proportions of confirmed cases were 
documented in the months of November, 
December and June at 11.1%, 8.1% and 7.2%, 
respectively. It was also found that patients who 
visited the health center in the month of December 
were more than 4 times likely to be malaria 
infected as compared with those who came in the 
first month of Ethiopian calendar, September, 
[AOR: 4.2, 95%CI  (2.374-7.560),  p value 0.000]. 
The distribution of malaria also showed a 
significant difference in the month of November, 
January, April, July and August (p value <0.05). 
According to different reports, in most parts of the 
country, the peak periods of malaria transmission 
occur from September to November, following the 
main rainy seasons, and from May to June, 
following the small rainy season (12,14,15). This 
makes our report consistent with the national 
report. A similar finding was also reported by 
Yewhalaw et al. in 2013 in the country (22). The 
unstable malaria transmission patterns make 
Ethiopia prone to focal and multifocal epidemics 
that have on occasion caused catastrophic public 
health emergencies (15). The prevalence of 
malaria over the five years’ period in the present 
study did not show typical trend/direction, instead 
there were ups and downs ranging from 4.1% to 
6.3% which might indicate inconsistent 
intervention measures taken to reduce the burden 
of the disease in Ethiopia. 
          In this study, it was found that females were 
1.3 times more likely to be positive for malaria 
than males [AOR: 1.3, 95%CI (1.101-1.638), p 
value 0.004].  This difference may be related to 
their relative low immune status compared with 
males. In this case, this finding is in line with the 
reports of the world malaria report (16). Similarly, 
it was found that patients in the age group above 
15 were 1.9 times more likely to be infected with 
malaria than individuals under the age of 5, [AOR: 
1.9 95%CI (1.498-2.455), p value 0.000]. This 
might be related with their frequent outdoor 
activities.  
Due to its retrospective nature, the study 
lacks  detailed clinical picture of patients which 
might have a determinant factor to show the 
complete picture of the study subjects. This calls 
for proper documentation of patient data. It would 
also be useful to know the percentage of malaria 
infected people and who were not presenting at the 
health center with suspected malaria. However, 
the report of our study will be an important source 
of data that will indirectly provide information 
concerning the implementation of malaria 
prevention and control measures in the study area 
where there is a high burden of the disease.  
In conclusion, despite the many efforts that 
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are in place to control it, malaria remains one of 
the most important causes of morbidity in our 
study area. The predominant identified species 
was P. falciparum. Thus, concerned stakeholders 
should strengthen sustainable malaria prevention 
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